Australia Medical Cannabis Market Size, Share & Trends Analysis Report By Application (Cancer, AIDS), By Sources (Hemp, Marijuana), By Derivatives (CBD, THC), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Segment Definitions
                        1.2.1. Sources
                        1.2.2. Application
                        1.2.3. Derivatives
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Sources outlook
                        2.2.2. Derivatives outlook
                        2.2.3. Application outlook
                    2.3. Competitive Insights
Chapter 3. Australia Medical Cannabis Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Rising Patient Population Adopting Cannabis Products
                            3.2.1.2. Increasing Preference for Cannabis Oils and Tinctures
                            3.2.1.3. Consumer Shift and Market Education for Cannabis In Australia
                            3.2.1.4. Entry Of International Players
                            3.2.1.5. Growing Legalization of Cannabis-Based CBD Products
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Stringent Regulations
                            3.2.2.2. Illicit Cannabis Trade
                            3.2.2.3. Incomplete Evidence Regarding the Effectiveness Of Medical Marijuana
                    3.3. Regulatory Scenario
                    3.4. Australia Medical Cannabis Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s
                        3.4.2. Bargaining power of suppliers
                        3.4.3. Bargaining power of buyers
                        3.4.4. Threat of substitutes
                        3.4.5. Threat of new entrants
                        3.4.6. Competitive rivalry
                    3.5. PESTEL Analysis
                        3.5.1. Political landscape
                        3.5.2. Economic landscape
                        3.5.3. Social landscape
                        3.5.4. Technological landscape
                        3.5.5. Environmental landscape
                        3.5.6. Legal landscape
                    3.6. Impact of COVID-19 Pandemic on Australia Medical Cannabis Market
                    3.7. Opportunity Analysis
                    3.8. Australia Medical Cannabis User Pool
                    3.9. Number of Medical Cannabis Prescriptions (2023)
Chapter 4. Australia Medical Cannabis Market: Sources Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Australia Medical Cannabis Market: Sources Movement Analysis
                    4.3. Australia Medical Cannabis Market by Sources Outlook (USD Million)
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.5. Hemp
                        4.5.1. Hemp Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.2. Hemp CBD Oil
                            4.5.2.1. Hemp CBD Oil Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.3. Industrial Hemp
                            4.5.3.1. Industrial Hemp Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Marijuana
                        4.6.1. Marijuana Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.2. Flower
                            4.6.2.1. Flower Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.6.3. Oil and Tinctures
                            4.6.3.1. Oil and Tinctures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Australia Medical Cannabis Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Australia Medical Cannabis Market: Application Movement Analysis
                    5.3. Australia Medical Cannabis Market by Application Outlook (USD Million)
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.5. Cancer
                        5.5.1. Cancer Market estimates and forecast 2018 - 2030 (USD Million)
                    5.6. Chronic Pain
                        5.6.1. Chronic Pain Market estimates and forecast 2018 - 2030 (USD Million)
                    5.7. Anxiety and Depression
                        5.7.1. Anxiety and Depression Market estimates and forecast 2018 - 2030 (USD Million)
                    5.8. Arthritis
                        5.8.1. Arthritis Market estimates and forecast 2018 - 2030 (USD Million)
                    5.9. Diabetes
                        5.9.1. Diabetes Market estimates and forecast 2018 - 2030 (USD Million)
                    5.10. Glaucoma
                        5.10.1. Glaucoma Market estimates and forecast 2018 - 2030 (USD Million)
                    5.11. Migraines
                        5.11.1. Migraines Market estimates and forecast 2018 - 2030 (USD Million)
                    5.12. Epilepsy
                        5.12.1. Epilepsy Market estimates and forecast 2018 - 2030 (USD Million)
                    5.13. Multiple Sclerosis
                        5.13.1. Multiple Sclerosis Market estimates and forecast 2018 - 2030 (USD Million)
                    5.14. AIDS
                        5.14.1. AIDS Market estimates and forecast 2018 - 2030 (USD Million)
                    5.15. Amyotrophic Lateral Sclerosis
                        5.15.1. Amyotrophic Lateral Sclerosis Market estimates and forecast 2018 - 2030 (USD Million)
                    5.16. Alzheimer’s Disease
                        5.16.1. Alzheimer’s Disease Market estimates and forecast 2018 - 2030 (USD Million)
                    5.17. Post-traumatic Stress Disorder (PTSD)
                        5.17.1. Post-traumatic Stress Disorder (PTSD) Market estimates and forecast 2018 - 2030 (USD Million)
                    5.18. Parkinson's Disease
                        5.18.1. Parkinson's Disease Market estimates and forecast 2018 - 2030 (USD Million)
                    5.19. Tourette’s Syndrome
                        5.19.1. Tourette’s Syndrome Market estimates and forecast 2018 - 2030 (USD Million)
                    5.20. Others
                        5.20.1. Others Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Australia Medical Cannabis Market: Derivatives Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Australia Medical Cannabis Market: Derivatives Movement Analysis
                    6.3. Australia Medical Cannabis Market by Derivatives Outlook (USD Million)
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    6.5. CBD
                        6.5.1. CBD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. THC
                        6.6.1. THC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Others
                        6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Market Participant Categorization
                    7.2. Key Company Profiles
                        7.2.1. Cann Group Limited
                            7.2.1.1. Company overview
                            7.2.1.2. Financial performance
                            7.2.1.3. Product benchmarking
                            7.2.1.4. Strategic initiatives
                        7.2.2. Zelira Therapeutics
                            7.2.2.1. Company overview
                            7.2.2.2. Financial performance
                            7.2.2.3. Product benchmarking
                            7.2.2.4. Strategic initiatives
                        7.2.3. AusCann Group Holdings Ltd.
                            7.2.3.1. Company overview
                            7.2.3.2. Financial performance
                            7.2.3.3. Product benchmarking
                            7.2.3.4. Strategic initiatives
                        7.2.4. Bod Australia
                            7.2.4.1. Company overview
                            7.2.4.2. Financial performance
                            7.2.4.3. Product benchmarking
                            7.2.4.4. Strategic initiatives
                        7.2.5. Althea Group
                            7.2.5.1. Company overview
                            7.2.5.2. Financial performance
                            7.2.5.3. Product benchmarking
                            7.2.5.4. Strategic initiatives
                        7.2.6. ECOFIBRE
                            7.2.6.1. Company overview
                            7.2.6.2. Financial performance
                            7.2.6.3. Product benchmarking
                            7.2.6.4. Strategic initiatives
                        7.2.7. Botanix Pharmaceuticals
                            7.2.7.1. Company overview
                            7.2.7.2. Financial performance
                            7.2.7.3. Product benchmarking
                            7.2.7.4. Strategic initiatives
                        7.2.8. EPSILON
                            7.2.8.1. Company overview
                            7.2.8.2. Financial performance
                            7.2.8.3. Product benchmarking
                            7.2.8.4. Strategic initiatives
                        7.2.9. Little Green Pharma
                            7.2.9.1. Company overview
                            7.2.9.2. Financial performance
                            7.2.9.3. Product benchmarking
                            7.2.9.4. Strategic initiatives
                        7.2.10. Incannex
                            7.2.10.1. Company overview
                            7.2.10.2. Financial performance
                            7.2.10.3. Product benchmarking
                            7.2.10.4. Strategic initiatives
                        7.2.11. Bod Australia
                            7.2.11.1. Company overview
                            7.2.11.2. Financial performance
                            7.2.11.3. Product benchmarking
                            7.2.11.4. Strategic initiatives
                        7.2.12. Cann Group Limited
                            7.2.12.1. Company overview
                            7.2.12.2. Financial performance
                            7.2.12.3. Product benchmarking
                            7.2.12.4. Strategic initiatives
                        7.2.13. ECOFIBRE
                            7.2.13.1. Company overview
                            7.2.13.2. Financial performance
                            7.2.13.3. Product benchmarking
                            7.2.13.4. Strategic initiatives 

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Australia medical cannabis market, by sources, 2018 - 2030 (USD Million)
Table 4 Australia medical cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Australia medical cannabis market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Australia Medical Cannabis Market Segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Australia medical cannabis market: Sources movement analysis
Fig. 12 Australia medical cannabis market: Sources outlook and key takeaways
Fig. 13 Hemp market estimates and forecast, 2018 - 2030
Fig. 14 Hemp CBD oil market estimates and forecast, 2018 - 2030
Fig. 15 Industrial hemp market estimates and forecast, 2018 - 2030
Fig. 16 Marijuana market estimates and forecast, 2018 - 2030
Fig. 17 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Oil & tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Australia medical cannabis market: Derivatives movement analysis
Fig. 20 Australia medical cannabis market: Derivatives outlook and key takeaways
Fig. 21 CBD market estimates and forecast, 2018 - 2030
Fig. 22 THC market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Australia medical cannabis market: Application movement analysis
Fig. 25 Australia medical cannabis market: Application outlook and key takeaways
Fig. 26 Cancer market estimates and forecast, 2018 - 2030
Fig. 27 Chronic pain market estimates and forecast, 2018 - 2030
Fig. 28 Anxiety and depression market estimates and forecast, 2018 - 2030
Fig. 29 Arthritis market estimates and forecast, 2018 - 2030
Fig. 30 Diabetes market estimates and forecast, 2018 - 2030
Fig. 31 Glaucoma market estimates and forecast, 2018 - 2030
Fig. 32 Migraines market estimates and forecast, 2018 - 2030
Fig. 33 Epilepsy market estimates and forecast, 2018 - 2030
Fig. 34 Multiple sclerosis market estimates and forecast, 2018 - 2030
Fig. 35 AIDS market estimates and forecast, 2018 - 2030
Fig. 36 Amyotrophic lateral sclerosis market estimates and forecast, 2018 - 2030
Fig. 37 Alzheimer’s disease market estimates and forecast, 2018 - 2030
Fig. 38 Post-traumatic stress disorder (PTSD) market estimates and forecast, 2018 - 2030
Fig. 39 Parkinson's disease market estimates and forecast, 2018 - 2030
Fig. 40 Tourette’s syndrome market estimates and forecast, 2018 - 2030
Fig. 41 Others market estimates and forecast, 2018 - 2030
Fig. 42 Market share of key market players- Australia medical cannabis market